Top

Unexplained fever? Malaria might be a possible diagnosis regardless of travel history, says CDC...

Judge’s Decision Would Make Some No-Cost Cancer Screenings a Thing of the Past

One Texas Judge Will Decide Fate of Abortion Pill Used by Millions of American Women

EU drug regulator has not found any signs of Pfizer COVID shot linking to stroke

New York nurses reach deals on third day of strike

Tag: CML

Biomarker, Innovation

Clinical Challenges: Discontinuing TKIs in Chronic Myeloid Leukemia

December 11, 2020

Via: MedPageToday

Treatment-free remission is now regarded as a primary aim of patients with long-term chronic myeloid leukemia (CML). Starting with the approval of imatinib in 2001, the effectiveness of tyrosine kinase inhibitors (TKIs) has resulted in significant improvements in outcomes for […]

Tag: CML

Clinical Challenges: Discontinuing TKIs in Chronic Myeloid Leukemia

Latest Publications

Revvity introduces automated tuberculosis testing platform

Neuronoff completes first-in-human trial for Injectrode to treat chronic pain

The Future of Human Health May Require Unlocking Access to Our Health Data

Tag: CML

Clinical Challenges: Discontinuing TKIs in Chronic Myeloid Leukemia

Trending

Tags

Latest Publications

Revvity introduces automated tuberculosis testing platform

Neuronoff completes first-in-human trial for Injectrode to treat chronic pain

The Future of Human Health May Require Unlocking Access to Our Health Data